Enhanced response of melanoma cells to MEK inhibitors following unbiased IGF-1R down-regulation

Due to its ability to compensate for signals lost following therapeutic MAPK-inhibition, insulin-like growth factor type 1 receptor (IGF-1R) co-targeting is a rational approach for melanoma treatment. However IGF-1R conformational changes associated with its inhibition can preferentially activate MA...

Descripción completa

Detalles Bibliográficos
Autores principales: Suleymanova, Naida, Crudden, Caitrin, Worrall, Claire, Dricu, Anica, Girnita, Ada, Girnita, Leonard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669887/
https://www.ncbi.nlm.nih.gov/pubmed/29137261
http://dx.doi.org/10.18632/oncotarget.19286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669887/
https://www.ncbi.nlm.nih.gov/pubmed/29137261
http://dx.doi.org/10.18632/oncotarget.19286

Ejemplares similares